• Moran Amit, Yoav Binenbaum, Jacob T Cohen, and Ziv Gil.
• Department of Otolaryngology Head and Neck Surgery, Rambam Medical Center, the Technion, Israel Institute of Technology, Haifa, Israel.
• J. Am. Coll. Surg.. 2013 Aug 1;217(2):221-5.

BackgroundThis single-blinded, prospective, randomized controlled trial compared the efficacy and safety of an oxidized cellulose patch (Surgicel [Johnson and Johnson]) with conventional procedures for achieving hemostasis in thyroid surgery.Study DesignThe study included 190 patients scheduled for thyroidectomy. Patients were randomized into 1 conventionally treated (ligatures and bipolar electrocautery) group (n = 92) and a second group, which additionally received Surgicel (n = 98).ResultsThe groups were demographically and clinically matched and had similar wound drainage volumes and mean duration of surgery. Postoperative bleeding rate was greater in the Surgicel group, yet the difference didn't reach statistical significance (p = 0.054). There were no significant group differences in postoperative wound infection, seroma, hypocalcemia, or recurrent laryngeal nerve palsy. Time to drain removal and length of hospital stay were significantly shorter in the conventional group (p < 0.001).ConclusionsRoutine use of an oxidized cellulose hemostatic agent has no advantage over conventional hemostasis and is potentially harmful in thyroid surgery.Copyright © 2013 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

28 keywords...

hide…